Mechanistically, LINC-PINT interacts with PRC2 at a few tumor-invasion-related gene loci, such as Early Growth Response 1 (EGR1) and Integrin alpha 3 (ITGA3), and induces their silencing, ultimately repressing cancer cell migration [140]. The gene discussed is EGR1; the disease is cancer.